Cite
Kadri S, Lee J, Fitzpatrick C, et al. Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL. Blood Adv. 2017;1(12):715-727doi: 10.1182/bloodadvances.2016003632.
Kadri, S., Lee, J., Fitzpatrick, C., Galanina, N., Sukhanova, M., Venkataraman, G., Sharma, S., Long, B., Petras, K., Theissen, M., Ming, M., Kobzev, Y., Kang, W., Guo, A., Wang, W., Niu, N., Weiner, H., Thirman, M., Stock, W., Smith, S. M., Nabhan, C., Segal, J. P., Lu, P., & Wang, Y. L. (2017). Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL. Blood advances, 1(12), 715-727. https://doi.org/10.1182/bloodadvances.2016003632
Kadri, Sabah, et al. "Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL." Blood advances vol. 1,12 (2017): 715-727. doi: https://doi.org/10.1182/bloodadvances.2016003632
Kadri S, Lee J, Fitzpatrick C, Galanina N, Sukhanova M, Venkataraman G, Sharma S, Long B, Petras K, Theissen M, Ming M, Kobzev Y, Kang W, Guo A, Wang W, Niu N, Weiner H, Thirman M, Stock W, Smith SM, Nabhan C, Segal JP, Lu P, Wang YL. Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL. Blood Adv. 2017 May 02;1(12):715-727. doi: 10.1182/bloodadvances.2016003632. eCollection 2017 May 09. PMID: 29296715; PMCID: PMC5728051.
Copy
Download .nbib